Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0850
-0.0060 (-6.59%)
Sep 15, 2025, 4:00 PM EDT
Zomedica Market Cap
Zomedica has a market cap or net worth of $83.39 million as of September 15, 2025. Its market cap has decreased by -33.57% in one year.
Market Cap
83.39M
Enterprise Value
27.84M
Revenue
28.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since July 29, 2016, Zomedica's market cap has increased from 65.86M to 83.39M, an increase of 26.63%. That is a compound annual growth rate of 2.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 89.18M | -24.17% |
| Dec 31, 2024 | 117.59M | -40.06% |
| Dec 29, 2023 | 196.19M | 22.82% |
| Dec 30, 2022 | 159.73M | -46.82% |
| Dec 31, 2021 | 300.34M | 130.90% |
| Dec 31, 2020 | 130.07M | 263.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 750.21M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 359.27M |
| American Oncology Network | 353.52M |